Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12618001229268Phase 3Recruiting
Phase 3, open-label trial of ceftriaxone, metronidazole and amoxicillin + clavulanic acid in appendicitis (2 arms), sponsored by Townsville University Hospital. Primary endpoints: Freedom from appendicectomy within 6 weeks and Successful appendicectomy. Started Dec 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12618001229268.